254 related articles for article (PubMed ID: 33597867)
1. An Updated Review of the Diagnostic Methods in Delayed Drug Hypersensitivity.
Copaescu A; Gibson A; Li Y; Trubiano JA; Phillips EJ
Front Pharmacol; 2020; 11():573573. PubMed ID: 33597867
[TBL] [Abstract][Full Text] [Related]
2. The Combined Utility of Ex Vivo IFN-γ Release Enzyme-Linked ImmunoSpot Assay and In Vivo Skin Testing in Patients with Antibiotic-Associated Severe Cutaneous Adverse Reactions.
Trubiano JA; Strautins K; Redwood AJ; Pavlos R; Konvinse KC; Aung AK; Slavin MA; Thursky KA; Grayson ML; Phillips EJ
J Allergy Clin Immunol Pract; 2018; 6(4):1287-1296.e1. PubMed ID: 29100867
[TBL] [Abstract][Full Text] [Related]
3. Tools to improve the diagnosis and management of T-cell mediated adverse drug reactions.
Copaescu AM; Ben-Shoshan M; Trubiano JA
Front Med (Lausanne); 2022; 9():923991. PubMed ID: 36313986
[TBL] [Abstract][Full Text] [Related]
4. The Role of In Vivo and Ex Vivo Diagnostic Tools in Severe Delayed Immune-Mediated Adverse Antibiotic Drug Reactions.
Copaescu A; Mouhtouris E; Vogrin S; James F; Chua KYL; Holmes NE; Douglas A; Slavin MA; Cleland H; Zubrinich C; Aung AK; Goh MSY; Phillips EJ; Trubiano JA;
J Allergy Clin Immunol Pract; 2021 May; 9(5):2010-2015.e4. PubMed ID: 33453452
[TBL] [Abstract][Full Text] [Related]
5. Novel interferon-γ enzyme-linked immunoSpot assay using activated cells for identifying hypersensitivity-inducing drug culprits.
Kato K; Kawase A; Azukizawa H; Hanafusa T; Nakagawa Y; Murota H; Sakaguchi S; Asada H; Katayama I
J Dermatol Sci; 2017 Jun; 86(3):222-229. PubMed ID: 28330775
[TBL] [Abstract][Full Text] [Related]
6. The measurement of drug-induced interferon γ-releasing cells and lymphocyte proliferation in severe cutaneous adverse reactions.
Suthumchai N; Srinoulprasert Y; Thantiworasit P; Rerknimitr P; Tuchinda P; Chularojanamontri L; Rerkpattanapipat T; Chanprapaph K; Disphanurat W; Chakkavittumrong P; Tovanabutra N; Srisuttiyakorn C; Sukasem C; Klaewsongkram J;
J Eur Acad Dermatol Venereol; 2018 Jun; 32(6):992-998. PubMed ID: 29478292
[TBL] [Abstract][Full Text] [Related]
7. Dose Dependent Antimicrobial Cellular Cytotoxicity-Implications for
Copaescu A; Choshi P; Pedretti S; Mouhtouris E; Peter J; Trubiano JA
Front Pharmacol; 2021; 12():640012. PubMed ID: 34447304
[No Abstract] [Full Text] [Related]
8. In-vivo and ex-vivo tests for culprit drugs identification in severe cutaneous adverse drugs reactions.
Sittiwattanawong P; Kantikosum K; Charoenchaipiyakul K; Pootongkam S; Asawanonda P; Kerr SJ; Thantiworasit P; Sodsai P; Hirankarn N; Klaewsongkram J; Rerknimitr P
J Dermatol; 2024 Apr; ():. PubMed ID: 38605448
[TBL] [Abstract][Full Text] [Related]
9. Blister fluid as a cellular input for
Awad A; Mouhtouris E; Nguyen-Robertson CV; Holmes N; Chua KYL; Copaescu A; James F; Goh MS; Aung AK; Godfrey DI; Philips EJ; Gibson A; Almeida CF; Trubiano JA;
J Allergy Clin Immunol Glob; 2022 Feb; 1(1):16-21. PubMed ID: 37780076
[TBL] [Abstract][Full Text] [Related]
10. Delabeling Delayed Drug Hypersensitivity: How Far Can You Safely Go?
Lehloenya RJ; Peter JG; Copascu A; Trubiano JA; Phillips EJ
J Allergy Clin Immunol Pract; 2020 Oct; 8(9):2878-2895.e6. PubMed ID: 33039012
[TBL] [Abstract][Full Text] [Related]
11. Analysis of HLA-B Allelic Variation and IFN-γ ELISpot Responses in Patients with Severe Cutaneous Adverse Reactions Associated with Drugs.
Klaewsongkram J; Sukasem C; Thantiworasit P; Suthumchai N; Rerknimitr P; Tuchinda P; Chularojanamontri L; Srinoulprasert Y; Rerkpattanapipat T; Chanprapaph K; Disphanurat W; Chakkavittumrong P; Tovanabutra N; Srisuttiyakorn C;
J Allergy Clin Immunol Pract; 2019 Jan; 7(1):219-227.e4. PubMed ID: 29800753
[TBL] [Abstract][Full Text] [Related]
12. Delayed hypersensitivity to antiepileptic drugs in children.
Mori F; Blanca-Lopez N; Caubet JC; Demoly P; Du Toit G; Gomes ER; Kuyucu S; Romano A; Soyer O; Tsabouri S; Atanaskovic-Markovic M
Pediatr Allergy Immunol; 2021 Apr; 32(3):425-436. PubMed ID: 33205474
[TBL] [Abstract][Full Text] [Related]
13. Aminopenicillin-associated exanthem: lymphocyte transformation testing revisited.
Trautmann A; Seitz CS; Stoevesandt J; Kerstan A
Clin Exp Allergy; 2014 Dec; 44(12):1531-8. PubMed ID: 25323308
[TBL] [Abstract][Full Text] [Related]
14. ELISpot: a new tool for the detection of nickel sensitization.
Lindemann M; Böhmer J; Zabel M; Grosse-Wilde H
Clin Exp Allergy; 2003 Jul; 33(7):992-8. PubMed ID: 12859458
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of Lymphocyte Transformation Test Results in Patients with Delayed Hypersensitivity Reactions following the Use of Anticonvulsant Drugs.
Karami Z; Mesdaghi M; Karimzadeh P; Mansouri M; Taghdiri MM; Kayhanidoost Z; Jebelli B; Shekarriz Foumani R; Babaie D; Chavoshzadeh Z
Int Arch Allergy Immunol; 2016; 170(3):158-62. PubMed ID: 27560351
[TBL] [Abstract][Full Text] [Related]
16. Lymphocyte transformation test: History and current approaches.
Sachs B; Fatangare A; Sickmann A; Glässner A
J Immunol Methods; 2021 Jun; 493():113036. PubMed ID: 33745950
[TBL] [Abstract][Full Text] [Related]
17. Role of in vivo and in vitro Tests in the Diagnosis of Severe Cutaneous Adverse Reactions (SCAR) to Drug.
Bergmann MM; Caubet JC
Curr Pharm Des; 2019; 25(36):3872-3880. PubMed ID: 31696801
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of IFN-γ Enzyme-linked Immunospot Assay (ELISPOT) as a First-line Test in the Diagnosis of Non-Immediate Hypersensitivity to Amoxicillin and Penicillin.
Sedláčková L; Průcha M; Poláková I; Míková B
Prague Med Rep; 2018; 119(1):30-42. PubMed ID: 29665345
[TBL] [Abstract][Full Text] [Related]
19. A diagnostic protocol for evaluating nonimmediate reactions to aminopenicillins.
Romano A; Quaratino D; Di Fonso M; Papa G; Venuti A; Gasbarrini G
J Allergy Clin Immunol; 1999 Jun; 103(6):1186-90. PubMed ID: 10359904
[TBL] [Abstract][Full Text] [Related]
20. ELISpot assay as a diagnostic tool in drug hypersensitivity reactions.
Porebski G; Piotrowicz-Wojcik K; Spiewak R
J Immunol Methods; 2021 Aug; 495():113062. PubMed ID: 33940020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
